HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.

Abstract
PTEN: and beta-catenin mutations constitute the predominant genetic alterations in endometrioid carcinomas of the endometrium. PTEN encodes a dual-specificity phosphatase with lipid phosphatase and protein tyrosine phosphatase activities that regulate both apoptosis and interactions with the extracellular matrix. Recent studies have associated PTEN mutations with tumorigenesis of prostate carcinoma via the Wnt signaling pathway, leading to nuclear beta-catenin accumulation. To elucidate the potential interaction of PTEN and beta-catenin in endometrial cancer, we performed mutation analyses of the entire PTEN gene and of exon 3 of the beta-catenin gene that is most frequently targeted by mutations. A total of 82 endometrial carcinomas comprising 62 type I endometrioid carcinomas and 20 type II high-grade carcinomas were investigated. In addition in a subset of 22 carcinomas, the intracellular beta-catenin distribution was analyzed by immunohistochemistry. Overall, 20 (24.4%) of 82 tumors revealed mutations in the PTEN gene, and 16 (19.5%) of 82, in the beta-catenin gene. Six tumors (7.3%) showed mutations in both the PTEN and beta-catenin gene. Mutations were mainly detected in endometrioid carcinomas of the endometrium. As expected, a striking nuclear accumulation of beta-catenin could be shown in tumors with beta-catenin mutations. In the vast majority of tumors with PTEN mutations, a regular staining pattern of the cytoplasmic and membranous compartments was found. We therefore conclude that, in contrast to prostate cancer, mutations in the PTEN gene seem not to affect cellular distribution of the beta-catenin protein in endometrial carcinomas.
AuthorsB Wappenschmidt, E Wardelmann, A Gehrig, T Schöndorf, N Maass, G Bonatz, A-M Gassel, T Pietsch, P Mallmann, B H F Weber, R K Schmutzler
JournalHuman pathology (Hum Pathol) Vol. 35 Issue 10 Pg. 1260-5 (Oct 2004) ISSN: 0046-8177 [Print] United States
PMID15492994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CTNNB1 protein, human
  • Cytoskeletal Proteins
  • Trans-Activators
  • Tumor Suppressor Proteins
  • beta Catenin
  • Phosphoric Monoester Hydrolases
  • PTEN Phosphohydrolase
  • PTEN protein, human
Topics
  • Carcinoma, Endometrioid (genetics, metabolism, pathology)
  • Cell Nucleus (metabolism)
  • Cytoskeletal Proteins (metabolism)
  • DNA Mutational Analysis
  • Endometrial Neoplasms (genetics, metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Mutation
  • PTEN Phosphohydrolase
  • Phosphoric Monoester Hydrolases (genetics)
  • Trans-Activators (metabolism)
  • Tumor Suppressor Proteins (genetics)
  • beta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: